Merck MRK announced FDA approval for its prophylactic long-acting monoclonal antibody, clesrovimab, for the prevention of RSV ...

Shares of Summit Therapeutics SMMT tanked nearly 31% on Friday after it reported mixed results from the phase III HARMONi study, which evaluated its investigational antibody ivonescimab in certain ...

Plant Services Smart Minute is a content based enewsletter where readers will find exclusive content, relevant industry news, useful case studies, access to Plant Services on-demand webcasts, and ...

Germany’s Merck MRK-6.82%decrease; red down pointing triangle KGaA shares dropped after the company slashed its full-year outlook on the back of uncertainty around tariffs and foreign-exchange ...

The latest price target for Merck & Co (NYSE:MRK) was reported by Citigroup on May 14, 2025. The analyst firm set a price target for $84.00 expecting MRK to rise to within 12 months (a possible 7. ...

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

Get the annual and quarterly balance sheets for Merck KGaA (MRK.DE) including details of assets, liabilities and shareholders’ equity.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

Short interest in Merck & Co Inc (NYSE:MRK) increased during the last reporting period, rising from 37.14M to 41.27M. This put 1.83% of the company's publicly available shares short. Short ...

We recently published a list of 10 Dirt Cheap Stocks To Invest In Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other dirt cheap stocks to ...